Automatic and empathic monitoring of all your patients
Leave us your email to have free access to the demo.
If you need more information, please contact us
As 2024 comes to an end, we look back on a year filled with impact and transformation, a journey that highlights just how far we’ve come. Tucuvi closes the year leading safe and precise Conversational AI, certified as a Medical Device in Europe, setting the standard for safety, precision, and trust in patient care.
Let’s delve into the milestones, challenges, and results that defined this year, as we continue transforming patient care and empowering clinical teams with clinical and safe conversational AI.
This year, Tucuvi’s Clinical Conversational AI, has continued empowering over 40 healthcare systems across multiple regions. By enabling better-informed decisions, improving patient outcomes, and ensuring timely interventions, LOLA has been instrumental in enhancing patient outcomes and transforming the care experience.
As a safe, regulated, and trusted Clinical AI Agent, LOLA supports over 50 clinical protocols, delivering significant impact across key medical specialties. In oncology, LOLA manages 15+ active protocols for various types of cancer, including colon, prostate, and breast cancer, helping optimize treatment pathways and follow-ups. In the respiratory field, LOLA has played a pivotal role in supporting patients with COPD and sleep apnea, improving symptom monitoring and long-term care management.
Beyond these, LOLA’s capabilities extend across a wide spectrum of specialties, including cardiology, surgery, emergency medicine, traumatology, and palliative care, among others. These diverse protocols have been the backbone of LOLA’s approach this year, spanning numerous clinical pathways and empowering healthcare teams to respond efficiently and effectively.
With an industry-leading accuracy of >99%, LOLA sets the standard for reliability and safety regarding autonomous clinical conversations between AI and patients.
In 2024, patient care remains at the heart of everything we do. With an average satisfaction score of 4.7/5, patients clearly value the support LOLA provides in managing their healthcare.
But the impact of LOLA extends beyond just numbers, it's reflected in the voices of those who interact with her daily. From patients finding comfort and reassurance in their conversations to clinical teams streamlining their workflows, LOLA has become an indispensable partner in healthcare.
To bring these stories to life, this year we’ve gathered direct testimonials from both patients and clinical teams, highlighting the transformative impact LOLA plays in improving efficiency and care delivery.
And as the saying goes, a picture is worth a thousand words, we’ve taken it a step further with a video, focus on Spanish speaking patients, where patients share firsthand how they feel when talking and interacting with LOLA.
Tucuvi's mission remains unchanged. In 2024, we have continued working with the goal of increasing the capacity of healthcare professionals and transforming healthcare systems through a safe and precise AI designed to improve the lives of patients, clinical teams, and the healthcare ecosystem as a whole. At the heart of these advancements is our commitment to healthcare professionals: listening to their needs and creating solutions that make their day-to-day tasks easier and more efficient.
The new version of Tucuvi Dashboard is a direct result of this approach, introducing key features like phone visits with scribe, enhanced clinical notes, an upgraded call review system, and a new Data Dashboard for real-time analytics, Tucuvi Data. Each feature has been thoughtfully designed to optimize workflows, reduce administrative burdens, and empower HCPs to further facilitate the management and follow-up of patients, ensuring the delivery of the best possible patient care.
And these innovations go one step further. The influence also extends to the scientific community, with publications in leading journals like the European Heart Journal Digital Health and the European Respiratory Society. These science papers highlight showcase impactful outcomes in key medical areas such as CPAP and TAVI.
Hospitals implementing Tucuvi's AI solutions demonstrate how these innovations are making a tangible difference in healthcare.
Our continuous development has garnered significant recognition.
Tucuvi received recognition from Forbes, Bessemer Ventures, Avia Marketplace, and the CUF and Ribera Salud Prize, being also featured in major media channels such as The Financial Times, ITV in the UK, TVE in Spain, and Wired Magazine.
And it’s not just the product is growing. Tucuvi's team, composed of clinical experts, engineers, AI specialists, and biomedical professionals from different fields, has expanded by +76.9% this year, a direct reflection of the increasing demand for LOLA and conversational AI solutions in healthcare worldwide.
As 2024 comes to a close and with a focus on 2025, our commitment remains: to continue expanding our impact, pushing the boundaries of technology, and, most importantly, transforming healthcare for the better, so every patient has access to the best healthcare.
Whether you want to scale your capacity of care, automate repetitive tasks, improve care team efficiency, or reduce relapses through early interventions, we have a solution for you.
Fill out the form and our team will get in touch with you soon.
.svg)
